首页|MRI动态增强与DWI扫描结合在乳腺癌诊断及新辅助化疗疗效评估中的应用研究

MRI动态增强与DWI扫描结合在乳腺癌诊断及新辅助化疗疗效评估中的应用研究

扫码查看
目的 分析MRI动态增强(DCE-MRI)与扩散加权成像(DWI)扫描结合在乳腺癌诊断及新辅助化疗疗效评估中的应用.方法 选取2019年2月至2023年2月本院收治的乳腺肿瘤患者80例.手术前后均行DWI和DCE-MRI扫描.以手术病理结果作为金标准,分析DWI、DCE-MRI以及联合检查与病理结果的Kappa一致性.比较乳腺癌患者治疗前后肿瘤表观弥散系数(ADC)值、前后、左右、上下直径和肿瘤体积以及乳腺癌患者化疗前后病灶时间-信号强度曲线(TIC)曲线的类型例数.结果 80例患者经手术病理学检查确诊恶性肿瘤患者16例,良性肿瘤患者64例.以手术病理结果作为金标准,DWI检查乳腺良恶性的敏感度和特异度分别为87.50%、71.88%,Kappa值=0.432;DCE-MRI检查乳腺良恶性的敏感度和特异度分别为81.25%、75.00%,Kappa值=0.431.DWI+DCE-MRI联合乳腺良恶性的敏感度和特异度分别为93.75%、71.88%,Kappa值=0.469.化疗后,肿瘤前后、左右、上下直径和体积明显小于化疗前(P<0.05).化疗前后,肿瘤ADC值比较,差异无统计学意义(P>0.05).化疗前后I型、Ⅱ型和Ⅲ型TIC曲线例数比较,差异具有统计学意义(P<0.05).结论 DCE-MRI联合DWI检查有效诊断乳腺良恶性,并精准反映出肿瘤新辅助化疗后组织形态学及TIC曲线变化,具有较高的临床应用价值.
Application of DCE-MRI Combined with DWI Scan in the Diagnosis of Breast Cancer and Curative Effect Evaluation of Neoadjuvant Chemotherapy
Objective To analyze the application of dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI)combined with diffusion-weighted imaging(DWI)scan in the diagnosis of breast cancer and curative effect evaluation of neoadjuvant chemotherapy.Methods A total of 80 patients with breast tumor admitted to the hospital were enrolled as the observation objects between February 2019 and February 2023.All underwent DWI and DCE-MRI scans before and after surgery.The results of operation and pathology were taken as the gold standard,and the consistency of DWI,DCE-MRI and Kappa between combined examination and pathology were analyzed.The tumor apparent diffusion coefficient(ADC),before and after treatment,left and right,upper and lower diameter,tumor volume and the type of time-signal intensity curve(TIC)curve of breast cancer patients before and after chemotherapy were compared.Results In the 80 patients with breast tumor,pathological examination showed that there were 16 cases with malignant tumors and 64 cases with benign tumors.According to the results of operation and pathology as the gold standard,the sensitivity and specificity of DWI for benign and malignant breast were 87.50%and 71.88%,respectively,and the Kappa value was 0.432.The sensitivity and specificity of DCE-MR in detecting benign and malignant breast were 81.25%and 75.00%respectively,and the Kappa value was 0.431.The sensitivity and specificity of DWI+DCE-MRI combined with benign and malignant breast were 93.75%and 71.88%respectively,and the Kappa value was 0.469.After chemotherapy,front-back,left-right and upper-lower diameters and tumor volume were significantly decreased(P<0.05).Before and after chemotherapy,there was no significant difference in ADC(P>0.05),but there were significant differences in number of type Ⅰ,type Ⅱ and type Ⅲ TIC curves(P<0.05).Conclusion DCE-MRI combined with DWI can effectively diagnose benign and malignant breast tumors,which can accurately reflect the changes of histomorphology and TIC curves after neoadjuvant chemotherapy.

Breast CancerNeoadjuvant ChemotherapyDiffusion-weighted ImagingDynamic Contrast-enhanced MRI

田捷、杨芝华、刘琴、杨宇

展开 >

湖南中医药大学(湖南长沙410000)

湘西自治州人民医院磁共振室(湖南湘西 416000)

湘西自治州人民医院超声科(湖南湘西 416000)

广东省佛山市南海区公共卫生医院功能科(广东佛山 528226)

湖南中医药大学第一附属医院放射科(湖南长沙 410000)

展开 >

乳腺癌 新辅助化疗 扩散加权成像 MRI动态增强

湖南省自然科学基金

2022JJ70114

2024

中国CT和MRI杂志
北京大学深圳临床医学院 北京大学第一医院

中国CT和MRI杂志

CSTPCD
影响因子:1.578
ISSN:1672-5131
年,卷(期):2024.22(4)
  • 19